Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5526_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Contents
- •1.1 Introduction
- •1.2 Pathophysiology
- •1.3 Case Presentation
- •1.4 Case Discussion
- •1.5 Clinical Characteristics
- •1.6 Diagnostic Algorithm
- •1.8 Management
- •1.9 Conclusion
- •References
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Case Presentation
- •2.4 Case Discussion
- •2.5 Clinical Characteristics
- •1.7 Differential Diagnosis
- •2.6 Diagnostic Algorithm
- •2.7 Management
- •2.8 Conclusion
- •References
- •3.1 Introduction
- •3.2 Pathophysiology
- •3.3 Case Presentation
- •3.4 Case Discussion
- •3.5 Clinical Characteristics
- •3.6 Diagnostic Algorithm
- •3.7 Management
- •3.8 Conclusion
- •References
- •4.1 Introduction
- •4.2 Pathophysiology
- •4.3 Case Presentation
- •4.4 Case Discussion
- •4.6 Diagnostic Algorithm
- •4.7 Management
- •4.8 Conclusion
- •References
- •5.1 Introduction
- •5.2 Pathophysiology
- •5.3 Case Presentation
- •5.4 Case Discussion
- •5.5 Diagnostic Algorithm
- •5.6 Management
- •5.7 Conclusion
- •References
- •6.1 Introduction
- •6.2 Pathogenesis
- •6.3 Case Presentation
- •6.4 Case Discussion
- •6.5 Diagnostic Algorithm
- •6.6 Management
- •6.7 Conclusion
- •References
- •7.1 Introduction
- •7.2 Pathophysiology
- •7.3 Case Presentation
- •7.5 Differential Diagnosis
- •7.7 The Following Strategies Are Essential
- •7.7.1 Acute Symptom Relief
- •7.7.1.1 Pharmacological Treatment
- •7.7.2.1 Pharmacologic Prophylaxis
- •7.8 Conclusion
- •References
- •8.1 Introduction
- •8.3 Case Study
- •8.4 Case Discussion
- •8.5 Clinical Management
- •8.7 Diagnosis
- •8.8 Treatment
- •8.9 Conclusion
- •References
- •9.1 Introduction
- •9.2 Case Presentation
- •9.4 Diagnosis Algorithm
- •9.5 Secondary SUNCT
- •9.6 Management
- •9.8 Conclusion
- •References
- •10.1 Introduction
- •10.2 Pathophysiology
- •10.3 Case Presentation
- •10.4 Case Discussion
- •10.5 Clinical Characteristics
- •10.6 Diagnostic Algorithm
- •10.7 Management
- •10.8 Conclusion
- •References
- •11.1 Introduction
- •11.2 Pathophysiology
- •11.3 Case Presentation
- •11.4 Case Discussion
- •11.5 Clinical Characteristics
- •11.6 Diagnostic Algorithm
- •11.6.1 Step 1: Detailed Patient History
- •11.8 Management
- •11.9 Conclusions
- •12.2 Pathophysiology
- •12.3 Case Presentation
- •12.4 Case Discussion
- •12.6 Treatment
- •12.7 Conclusion
- •References
- •References
- •12.1 Introduction
- •13.1 Introduction
- •13.2 Pathophysiology
- •13.3 Case Presentation
- •13.4 Case Discussion
- •13.5 Clinical Characteristics
- •13.6 Diagnostic Algorithm
- •13.7 Management
- •13.8 Conclusion
- •References
- •14.1 Introduction
- •14.2 Pathophysiology
- •14.3 Case Presentation
- •14.3.1 Clinical Case 1
- •14.3.2 Clinical Case 2
- •14.4 Case Discussion
- •14.5 Clinical Characteristics
- •14.7 Treatment/Management
- •14.8 Conclusion
- •References
- •15.1 Introduction
- •15.2 Case Presentation
- •15.3 Case Discussion
- •15.4 Diagnostic Algorithm
- •15.5 Pathophysiology
- •15.6 Clinical Presentation
- •15.6.1 External-Compression Headache (ECH)
- •15.6.2 External-Traction Headache (ETH)
- •15.7 Management
- •15.7.1 Nonpharmacological Strategies
- •15.7.2 Pharmacological Strategies
- •15.7.3 Patient Education and Awareness
- •15.8 Conclusion
- •References
- •16.1 Introduction
- •16.2 Pathophysiology
- •16.3 Case Presentation
- •16.4 Case Discussion
- •16.6 Diagnostic Algorithm
- •16.7 Management
- •16.8 Conclusion
- •References
- •17.1 Introduction
- •17.2 Pathophysiology
- •17.3 Case Presentation
- •17.4 Case Discussion
- •17.5 Clinical Characteristics
- •17.6 Diagnosis
- •17.7 Differential Diagnosis
- •17.8 Treatment
- •17.9 Conclusion
- •References
- •18.1 Introduction
- •18.2 Pathophysiology
- •18.3 Case Presentation
- •18.4 Case Discussion
- •18.5 Clinical Presentation
- •18.6 Diagnosis
- •18.7 Differential Diagnosis
- •18.8 Treatment
- •18.9 Conclusion
- •References
- •19.1 Introduction
- •19.2 Pathophysiology
- •19.3 Case Presentation
- •19.4 Case Discussion
- •19.5 Diagnostic Approach
- •19.6 Management
- •19.7 Conclusion
- •References
- •20.1 Introduction
- •20.3 Case Report
- •20.4 Case Discussion
- •20.6 Clinical Presentation
- •20.7 Diagnostic Algorithm
- •20.8 Conclusion
- •References
- •21.1 Introduction
- •21.2 Case Presentation
- •21.3 Clinical Characteristics
- •21.4 Diagnosis
- •21.5 Treatment
- •References
- •22.1 Introduction
- •22.3 Case Presentation 1
- •22.4 Case Discussion
- •22.5 Case Presentation 2
- •22.6 Case Discussion 2
- •22.7 Clinical Characteristics
- •22.8 Diagnostic Workup
- •22.9 Treatment
- •22.10 Prognosis
- •References
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Case Presentation
- •23.4 Case Discussion
- •23.6 Diagnostic Algorithm
- •23.7 Management
- •23.8 Conclusion
- •References
- •24.1 Introduction
- •24.2 Case Presentation
- •24.3 Case Discussion
- •24.4 Pathophysiology
- •24.6 Clinical Characteristics
- •24.8 Treatment Approaches
- •24.10 Conclusion
- •References
- •25.1 Introduction
- •25.2 Case Presentation
- •25.3 Case Discussion
- •25.4 Conclusion
- •References
- •26.1 Introduction
- •26.2 Pathophysiology
- •26.3 Case Presentation
- •26.4 Case Discussion
- •26.5 Clinical Characteristics
- •26.6 Diagnostic Algorithm
- •26.7 Management
- •26.8 Conclusion
- •References
- •27.1 Introduction
- •27.2 Case Presentations
- •27.3 Clinical Characteristics
- •27.4 Discussion
- •27.5 Conclusion
- •References
- •28.1 Introduction
- •28.2 Case Presentation
- •28.3 Case Discussion
- •28.4 Clinical Characteristics
- •28.5 Diagnosis
- •28.6 Conclusion
- •28.7 Key Messages
- •References
- •29.1 Introduction
- •29.2 Pathophysiology
- •29.3 Case Presentation
- •29.4 Clinical Presentation
- •29.5 Diagnosis
- •29.6 Treatment
- •29.7 Conclusion
- •References
- •30.1 Introduction
- •30.2 Clinical Case
- •30.3 Clinical Presentation
- •30.4 Differential Diagnosis
- •30.5 Diagnosis
- •30.6 Treatment
- •30.7 Conclusion
- •References
- •31.1 Introduction
- •31.2 Pathophysiology
- •31.3 Case Presentation
- •31.4 Case Discussion
- •31.5 Clinical Presentation
- •31.7 Conclusion
- •References
- •32.1 Introduction
- •32.2 Pathophysiology
- •32.3 Case Presentation
- •32.4 Case Discussion
- •32.6 Diagnosis
- •32.7 Additional Diagnostic Evaluations
- •32.8 Apply ICHD-3 Diagnostic Criteria [9]
- •32.10 Management
- •32.11 Conclusion
- •References
- •33.1 Introduction
- •33.2 Pathophysiology
- •33.3 Case Presentation
- •33.4 Clinical Characteristics
- •33.5 Diagnostic Algorithm
- •33.6 Treatment
- •33.7 Conclusion
- •References
- •34.1 Introduction
- •34.2 Pathophysiology
- •34.3 Case Presentation
- •34.4 Case Discussion
- •34.6 Diagnostic Algorithm
- •34.7 Treatment
- •34.8 Conclusion
- •References
- •35.1 Introduction
- •35.3 Case Presentation
- •35.4 Case Discussion
- •35.7 Treatment
- •35.7.1 Oxygen Therapy (100% Oxygen)
- •35.8 Conclusion
- •References
- •36.1 Introduction
- •36.2 Pathophysiology
- •36.3 Case Presentation
- •36.5 Diagnostic Algorithm
- •36.6 Treatment
- •36.7 Conclusion
- •References
- •37.1 Introduction
- •37.2 Pathophysiology
- •37.3 Case Presentation
- •37.4 Headache Characteristics
- •37.5 Case Discussion
- •37.6 Treatment
- •37.7 Conclusion
- •References
- •38.1 Introduction
- •38.2 Pathophysiology
- •38.3 Case Presentation
- •38.4 Clinical Presentation
- •38.5 Diagnostic Algorithm
- •38.6 Treatment
- •38.7 Conclusion
- •References
- •39.1 Introduction
- •39.3 Case Presentation
- •39.4 Case Discussion
- •39.6 ICHD-3 Diagnostic Criteria [28]
- •39.6.1 Diagnostic Criteria
- •39.7 Diagnostic Algorithm
- •39.9 Conclusion
- •References
- •40.1 Introduction
- •40.3 Case Presentation
- •40.4 Case Discussion
- •40.5.1 Diagnostic Algorithm
- •40.6 Treatment
- •40.7 Conclusion
- •References
- •41.1 Introduction
- •41.3 Case Presentation
- •41.4 Clinical Presentation
- •41.5 Differential Diagnosis
- •41.6 Conclusion
- •41.7 Key Messages
- •References
- •42.1 Introduction
- •42.2 Pathophysiology
- •42.3 Case Presentation
- •42.5 Case Discussion
- •42.6 Clinical Presentation
- •42.7 Diagnostic Algorithm [9]
- •42.8 Preeclampsia
- •42.9 Eclampsia
- •42.10 Fetal Assessment
- •42.11 Treatment
- •42.12 Antihypertensive Management [8]
- •42.14 Conclusion
- •References
- •43.1 Introduction
- •43.2 Pathophysiology
- •43.3 Case Presentation
- •43.4 Case Discussion
- •43.5 Clinical Manifestations
- •43.6 Diagnosis
- •43.7 Treatment
- •43.8 Conclusion
- •References
- •44.1 Introduction
- •44.2 Pathophysiology
- •44.3 Case Presentation
- •44.4 Case Discussion
- •44.6 Diagnostic Approach
- •44.7 Management
- •44.8 Conclusion
- •References
- •45.1 Introduction
- •45.2 Pathophysiology
- •45.3 Case Presentation
- •45.6 Treatment
- •45.7 Conclusion
- •References
- •46.1 Introduction
- •46.2 Pathophysiology
- •46.3 Case Presentation
- •46.4 Clinical Characteristics
- •46.5 Differential Diagnosis
- •46.6 Treatment
- •46.7 Conclusion
- •References
- •47.1 Introduction
- •47.2 Pathophysiology
- •47.3 Case Presentation
- •47.4 Case Discussion
- •47.5 Clinical Presentations
- •47.6 Diagnostic Algorithm
- •47.7 Differential Diagnosis
- •47.8 Treatment
- •47.9 Conclusion
- •References
- •48.1 Introduction
- •48.2 Pathophysiology
- •48.3 Case Presentation
- •48.4 Case Discussion
- •48.5 Clinical Characteristics
- •48.7 Treatment
- •48.8 Conclusion
- •References
- •49.1 Introduction
- •49.2 Pathophysiology
- •49.3 Case Presentation
- •49.4 Clinical Presentation
- •49.5 Diagnosis
- •49.6 Treatment
- •49.7 Conclusion
- •References
- •50.1 Introduction
- •50.2 Pathophysiology
- •50.3 Case Presentation
- •50.4 Case Discussion
- •50.5 Clinical Characteristics
- •50.6 Diagnosis
- •50.7 Treatment
- •50.8 Conclusion
- •References
- •51.1 Introduction
- •51.2 Case Presentation
- •51.3 Clinical Characteristics
- •51.4 Diagnosis
- •51.5 Treatment
- •51.6 Conclusion
- •References
- •52.1 Introduction
- •52.2 Pathophysiology
- •52.3 Case Presentation
- •52.4 Case Discussion
- •52.5 Clinical Characteristics
- •52.6 Diagnosis
- •52.6.1 Cervicogenic Headache
- •52.6.2 Migraine
- •52.6.3 Neck Pain
- •52.6.4 Demyelinating Lesions
- •52.6.5 Cervical Myelitis
- •52.6.6 Occipital Allodynia
- •52.6.7 Cervical Muscle Spasms
- •52.7 Treatment
- •52.7.2 Acupuncture
- •52.7.3 Transcutaneous Electrical Nerve Stimulations (TENS)
- •52.8 Minimally Invasive Treatment
- •52.8.1 Nerve Blocks
- •52.8.2 Botulinum Toxin A
- •52.8.3 Radio Frequency
- •52.8.4 Occipital Nerve Stimulation
- •52.9 Surgical Treatments
- •52.10 Conclusions
- •References
- •53.1 Introduction
- •53.2 Pathophysiology
- •53.3 Characteristics of Pain
- •53.4 Case Presentation
- •53.5 Case Discussion
- •53.6 Clinical Characteristics
- •53.8 Treatment
- •53.9 Conclusion
- •References
- •54.1 Introduction
- •54.2 Pathophysiology
- •54.3 Case Presentation
- •54.4 Case Discussion
- •54.5 Clinical Characteristics
- •54.6 Diagnostic Algorithm
- •54.7 Management
- •54.8 Conclusion
- •References
- •55.1 Introduction
- •55.2 Pathophysiology
- •55.3 Case Presentation

6 Episodic Syndromes That May Be Associated with Migraine: Cyclical Vomiting…
51
His rst episode of vomiting was around the age of 3years, and it was thought to
be due to a viral illness. During the following 2years, he experienced a total of 5
similar episodes, each lasting up to 24h, before returning to normal.
Over the past 2years, vomiting episodes became more frequent, occurring once
every 8–10 weeks. Each episode lasts between 12 and 48h and is often triggered by
stressful events, such as school difculties, excitement for a birthday party, or a
family holiday. Parents can predict the onset of the episodes with a change in the
child’s behaviour. They describe Adam as emotional, moody, tired and not interested in food on the day before the onset of vomiting. The next day, Adam becomes
distressed, cries, looks pale, refuses food, feels nauseated and within 1–2h starts
vomiting repeatedly. He vomits four to six times per hour, starting with undigested
food, followed by yellow-green uids, until he gets exhausted and becomes visibly
unwell and lethargic. Occasionally, Adam may complain of central abdominal pain
and frontal headache.
Adam was born normally at term and had no neonatal problems. He has no family history of similar illnesses. His mother has menstrual migraine. His father and
his 8-year-old brother are well and healthy.
Over the past 2years, Adam was taken to the local hospital on several occasions
because of suspected or conrmed dehydration, and he was given intravenous uids. The physical examination revealed no additional abnormal ndings, no fever,
and no focus of infection was identied.
During his current assessment, investigations revealed a normal blood count,
normal inammatory markers, normal blood tests for electrolytes, urea, creatinine,
liver function tests, and glucose, as well as a negative screen for coeliac disease. No
evidence of infection on throat swabs and urine culture. He also had a normal metabolic screen and upper gastrointestinal endoscopy. MRI scan of the brain was
also normal.
A diagnosis of CVS was made, and Adam was commenced on prophylactic treatment with pizotifen 0.5mg per night. Parents were given a written management
plan to implement during future episodes, including the administration of ondansetron melt tablets 4mg as early as possible after the onset of CVS.
6.4 Case Discussion
Adam’s clinical case demonstrates the difculties in making the diagnosis of CVS
in early childhood and, especially, in infancy. Although the diagnosis can be suspected early in the course of the disease, it cannot be conrmed until several episodes (at least ve) have been assessed and documented, exhibiting typical clinical
features, a normal physical examination and normal appropriate investigations.
Therefore, it is not surprising that in some cases the diagnosis can be delayed and
appropriate treatment is not given until several years later. Several factors may also
contribute to late diagnosis, including an atypical clinical presentation, episodes

52
Premonitory Phase Ictal Phase Resolution Phase
Time Day 1 Day 2Day 3
I. Abu-Arafeh
triggered by intercurrent illnesses, long intervals between episodes and possibly a
lack of awareness of the condition among clinical personnel.
Taking a thorough clinical history is crucial in assessing a child with CVS.Enquiry
about all symptoms throughout the whole duration of the episodes will identify, as
seen in the case of Adam above, the several phases of the CVS episode, the trigger
factors, premonitory symptoms, associated symptoms, relieving factors, response to
treatment and resolution of the episode and return to normal health (Fig.6.1).
Episodes of CVS can be triggered by stress, anxiety, missing sleep, missing
meals and intercurrent illnesses [18]. Premonitory symptoms may be noted 1–2days
before the onset of vomiting and may include excessive tiredness, yawning, a
change in mood and behaviour and loss of appetite. After the onset of vomiting,
children may complain of intense nausea, pallor, sleepiness, central abdominal pain
and frontal headache [19]. Excessive vomiting can cause dehydration, and parents
should be vigilant for the warning signs of dehydration, such as dry mouth, a raised
heart rate, a fast and weak pulse, a drop in level of consciousness and passing little
or no urine. Parents will be advised to seek medical advice if any of these symptoms
become apparent.
The start of resolution of the episode is manifested by the child becoming more
alert, talkative, and responsive to the family and the environment, followed by a
gradual reduction in nausea and vomiting, a return of a good appetite, and asking for
uids, drinks and food to eat. The child may want to sleep for a few hours or overnight. Upon awakening from sleep, the child feels well and gradually returns to
normal health.
Following several episodes, patients and parents can recognise the stereotypical
and almost identical nature of the episodes in their clinical presentation, duration
and frequency. Patients and parents can often predict the date of the next episode
with remarkable accuracy. They can also predict the evolution of symptoms and
pending dehydration and can appropriately seek medical advice or attend emergency department. Typical episodes are consistent with the International
Tiredness
Yawning
Mood changes
Fig. 6.1 Phases of the CVS episode
Intense nausea
Vomiting
Pallor
Lethargy
unwell
Less vomiting
Asking for a drink
Tolerating food
Feeling better

6 Episodic Syndromes That May Be Associated with Migraine: Cyclical Vomiting…
53
Table 6.1
Criteria for the diagnosis of cyclical vomiting syndrome
ICHD-3 (2018) [2] Rome-IV (2016) [3]
A. At least ve attacks of intense
nausea and vomiting, fullling
criteria B and C
B. Stereotypical in an individual
patient and recurring with
predictable periodicity
C.All of the following:
1. Nausea and vomiting occur at
least four times per hour
2. Attacks last 1h and up to
10days
3. Attacks occur at least 1week
apart
D. Complete freedom from symptoms
between attacks
E.Not attributed to another disorder
Must include all of the following:
1. The occurrence of two or more periods of intense,
unremitting nausea and paroxysmal vomiting, lasting
hours to days, within a 6-month period
2. Episodes are stereotypical in each patient
3. Episodes are separated by weeks to months, with
return to baseline health between episodes
4. After appropriate medical evaluation, the symptoms
cannot be attributed to another condition
Classication of Headache Disorders’ (2018) criteria or Rome-IV (2016) for the
diagnosis of CVS, as in Table6.1.
The clinical presentation of Adam was largely typical of CVS.The episodes are
discrete, time limited and resolve completely with return to normal health in
between episodes. Additionally, Adam has experienced normal growth, with a normal gain in weight and typical development. He did not have added features to suggest an alternate diagnosis, particularly in renal tract, the gastrointestinal system,
the central nervous system or symptoms related to a metabolic disorder. Therefore,
it was appropriate to carry out investigations early in the course of the disease when
the diagnosis could not be conrmed with certainty. His symptoms were in keeping
with the clinical criteria for the diagnosis of CVS (Table6.1). As in the case above,
a positive family history of migraine is common among children with CVS, but it is
not necessary to conrm the diagnosis.
6.5 Diagnostic Algorithm
The diagnosis of CVS is usually made by excluding other possible underlying
causes, which is an important criterion in both the ICHD-3 and Rome-IV [2, 3].
Some conditions can be excluded on clinical history and physical examination
alone. Other conditions that mimic CVS, especially if the presentation is atypical,
may require further investigations and should be carried out whenever there is
uncertainty about the diagnosis of CVS.
The choice of investigations depends on the predominant symptoms during episodes (Fig.6.2).

54
I. Abu-Arafeh
Assessment of the child
with suspected CVS
Typical episodes of CVS
≥ 2 episodes (Rome IV)
≥ 5 episodes (ICHD 3 )
Investigations are
not necessary
Gastrointestinal tract:
diarrhoea, constipation,
melena,
weight loss etc.
Renal system:
urine infection,
haematuria,
hypertension
Metabolic investigations if:
Episodes are triggered
by fasting or intercurrent
illnesses
Few or atypical
episodes of CVS
OR red flags
Investigations may
be necessary
according to
system involved
Neurologic investigations if:
seizures, focal deficits,
squint, ataxia,
papillodema, etc
Fig. 6.2 Flow chart on the assessment of the child with possible CVS
• In children with fever, it is prudent to exclude respiratory infections, urinary tract
infection and other serious infections such as meningitis and septicaemia.
• In children with episodes that are consistently triggered by missing meals or
intercurrent infections, it is important to exclude metabolic causes such as fatty
acid oxidation disorders by measuring blood lactate, pyruvate, ammonia, liver
function tests and plasma amino acids as well as urinary organic acids.
• Children presenting with abdominal pain, diarrhoea, constipation, food intoler-
ance and weight loss should be investigated with abdominal ultrasound, coeliac
screen, inammatory markers and upper gastrointestinal endoscopy.
• Investigations of the urinary tract should be carried out in children with unilateral
loin pain, dysuria, haematuria and recurrent urinary tract infections.
• Neurological investigations with brain imaging are important if the child pres-
ents with seizures, new focal neurological decits, motor incoordination, person-
ality change or papilloedema.

6 Episodic Syndromes That May Be Associated with Migraine: Cyclical Vomiting…
55
6.6 Management
Once the diagnosis is established, the child and the parents are given verbal and
written information about the disease in order for them to prepare and take part in
formalising the management plan at home and to liaise with teachers in the management of acute episodes at school. The management plan should take into account the
recurrent nature of the syndrome, the severity of illness and potential complications,
dehydration and on some occasions the need for hospital admission and administration of intravenous uids [20, 21]. The chronic nature of the disease may have an
adverse impact on the quality of life of the affected children and their families and
also on the child’s school attendance and education [22].
The earlier the treatment starts after the onset of symptoms the more successful the
outcome will be. Children will be taught to recognise the early features of the pending
or actual attack and also to inform parents or the adult carers of early symptoms. The
child should be allowed to rest in a quiet room and monitored by an adult carer. The
child will be given free access to uids to take small sips, paracetamol, if needed, and
anti-emetic. Early administration of anti-emetic medications will help in relieving or
reducing nausea and vomiting and also improve gastric emptying in order to allow reliable oral rehydration. The choice of which anti-emetic drug to give depends on local
availability, experience and licensing (Table 6.2) [23, 24]. Ondansetron is a
5-Hydroxytriptamin (5HT
Other medications can also be used with caution in regard to possible adverse reactions
such as cardiac arrhythmia and prolonged QT interval on electrocardiograph recording
with chronic use of domperidone and extrapyramidal side effect with metoclopramide.
Children with short and mild episodes may be managed successfully at home as
above and with rest, sleep and sips of uids. In some patients, the episode of vomiting starts suddenly and reaches a peak of intensity over a very short period of time
making oral treatment unachievable. In these children there is a high risk of dehydration and medical treatment with intravenous infusion is necessary [21, 25].
) antagonist and has a good safety prole in young children.
3
Table 6.2 Anti-emetic medications
Drug Action Single dose
Ondansetron 5HT
Metoclopramide D
Domperidone Dopamine
Cyclizine
3
antagonist
and 5HT4
2
antagonist
antagonist
Anti-
histamine
4mg 8mg 12h Oral melt tablet;
0.5mg/kg 20mg 12h Oral tablet; Oral
10mg 30mg 8h Oral tablet; Oral
25mg
(6–11years);
50mg
(12–17years)
Maximum
daily dose
75mg;
150mg
Minimum
interval Form for dose
Oral solution;
injectable
suspension;
injectable
suspension
8h Oral dispersible
tablet; injectable

56
I. Abu-Arafeh
Sumatriptan nasal spray may be administered to children aged 12 years and
above, and may help terminate the episode [26].
Children are advised to adopt a healthy lifestyle that reduces the risk and frequency of CVS.The advice includes a regular routine of getting enough sleep, eating regular meals, exercising regularly and getting good rest in between. Children
will be advised to monitor for specic triggers and try to avoid them as well as to
reduce intake of caffeinated drinks and avoid smoking.
Preventative medications for CVS may also be recommended for children with
frequent episodes, prolonged duration, severe risk of dehydration and inadequate
response to acute treatment. The decision to start preventive medication should be
taken jointly with the child and his parents in order to ensure compliance with the
recommendations.
Open observational studies have shown several medications to be effective
including the tricyclic antidepressant amitriptyline, the prokinetic erythromycin, the
anti-migraine drugs pizotifen, cyproheptadine and propranolol and other drugs such
as L-carnitine and coenzyme Q10 [27].
Amitriptyline, pizotifen and cyproheptadine are rst-line treatments for many
children due to their relatively good response and safety prole, but may need to be
avoided in overweight children as they may improve appetite and may lead to
weight gain.
Amitriptyline is recommended as the rst-line treatment due to its relative ease
of administration in a single daily dose at night and very little risk of adverse reactions. The recommended dose is about 0.25mg/day and can be increased in steps if
needed up to 1.0mg/day. Amitriptyline is available as liquid solution and in tablet forms.
Pizotifen is a safe and effective preventive treatment for migraine in children and
can be effective in the prevention of CVS. It is given as a single oral dose of
0.5–1.5mg at night. It is well tolerated, especially by young children.
Cyproheptadine has a dual action as an anti-histamine and calcium channel
antagonist (143, 144). It is administered orally in a daily dose of 0.25–0.5mg/kg,
split into two to three doses per day.
Propranolol, a beta-blocker, is an effective preventive treatment for migraine and
was also shown to be useful for the prevention of CVS in children. Propranolol is
administered orally in a dose of 1–2mg/kg, divided into two doses.
Erythromycin is a macrolide antibiotic with a prokinetic property that makes it
potentially useful in preventing vomiting, particularly in CVS.Erythromycin has a
good safety prole and is given in a dose of 10mg/kg twice a day.
Other potential preventive treatments include unarizine, L-carnitine and coenzyme Q10. The use of anti-epileptic drugs sodium valproate and topiramate is not
recommended in girls and young women with child-bearing potential.
CVS can have an adverse impact on children’s quality of life and education.
Children 5–18years of age with CVS and parents of children (2–18years old) with
CVS scored lower on Health-Related Quality of Life (HRQoL) questionnaire

6 Episodic Syndromes That May Be Associated with Migraine: Cyclical Vomiting…
57
compared to children with irritable bowel syndrome and other organic gastrointestinal disorders [28]. Duration of episodes and missing school days were signicantly associated with lower scores by children. Delayed diagnosis and missing
school days negatively impacted on parents’ scores [28].
It is estimated that in 24% of children with CVS, the condition resolves completely by late adolescence and early adult life. In about 30% the disease continues
and in 40–50% CVS will be replaced by migraine with or without aura [29].
6.7 Conclusion
Cyclical vomiting syndrome (CVS) is a relatively common paediatric condition,
affecting approximately 2% of children. It occurs equally in boys and girls, with a
typical onset between the ages of 5 and 6years. Diagnosis is based on the fullment
of either the ICHD-3 or Rome-IV criteria. Early and effective management of acute
episodes is essential to prevent complications such as dehydration. Preventive therapies not only reduce the frequency and severity of attacks but also contribute to
improved quality of life and better school attendance and educational outcomes.
Notably, one-third of affected children achieve complete remission by late adolescence, while nearly 50% go on to develop migraine with or without aura in early
adulthood.
References
1. Gee S.On tful or recurrent vomiting. St Bartholomew’s Hosp Rep. 1882;18:1–6.
2. Headache Classication Committee of the International Headache Society. The international
classication of headache disorders, 3rd edition. Cephalalgia. 2013;33(9):653.
3. Hyams JS, Di LoRenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M.Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2016;150:1456–68.
4. Abell TL, Adams KA, Boles RG, Bousvaros A, Chong SK, Fleisher DR, Hasler WL,
Hyman PE, Issenman RM, Li BU, Linder SL, Mayer EA, McCallum RW, Olden K,
Parkman HP, Rudolph CD, Taché Y, Tarbell S, Vakil N. Cyclic vomiting syndrome in
adults. Neurogastroenterol Motil. 2008;20(4):269–84.
2.2008.01113.x.
5. Abu-Arafeh I, Russell G.Cyclical vomiting syndrome in children: a population-based study. J
Pediatr Gastroenterol Nutr. 1995;21:454–8.
6. Ertekin V, Selimoglu MA, Altnkaynak S.Prevalence of cyclic vomiting syndrome in a sample
of Turkish school children in an urban area. J Clin Gastroenterol. 2006;40:896–8.
7. Cullen K, Macdonald WB.The periodic syndrome. Its nature and prevalence. Med J Aust.
1963;50(2):167–72.
8. Fitzpatrick E, Bourke B, Drumm B, Rowland M.The incidence of cyclic vomiting syndrome
in children: population-based study. Am J Gastroenterol. 2008;103(4):991–5; quiz 996. https://
doi.org/10.1111/j.1572- 0241.2007.01668.x. Epub 2007 Dec 5. PMID: 18070235.
https://doi.org/10.1111/j.1365- 298

58
9. Sagar RC, Sood R, Gracie DJ, Gold MJ, To N, Law GR, Ford AC.Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic.
Neurogastroenterol Motil. 2018;30(1):e13174. https://doi.org/10.1111/nmo.13174. Epub
2017 Jul 26.
10. Alfayyadh MM, Maksemous N, Sutherland HG, Lea RA, Grifths LR.Unravelling the genetic
landscape of hemiplegic migraine: exploring innovative strategies and emerging approaches.
Genes. 2024;15:443.
11. Lee J, Wong SA, Li BU, Boles RG.NextGen nuclear DNA sequencing in cyclic vomiting
syndrome reveals a signicant association with the stressinduced calcium channel (RYR2).
Neurogastroenterol Motil. 2015;27:990–6.
12. Ye Z, Xue A, Huang Y, Wu Q.Children with cyclic vomiting syndrome: phenotypes, disease
burden and mitochondrial DNA analysis. BMC Gastroenterol. 2018;18:104.
13. Boles RG, Chun N, Senadheera D, Wong LJ.Cyclic vomiting syndrome and mitochondrial
DNA mutations. Lancet. 1997;350:1299–300.
14. Salpietro CD, Briuglia S, Merlino MV, Di Bella C, Rigoli LA.Mitochondrial DNA mutation
(A3243GmtDNA) in a family with cyclic vomiting. Eur J Pediatr. 2003;162:727–8.
15. Chelimsky TC, Chelimsky GG.Autonomic abnormalities in cyclic vomiting syndrome. J
Pediatr Gastroenterol Nutr. 2007;44:326–30.
16. Fitzpatrick E, Bourke B, Drumm B, Rowland M.Outcome of children with cyclical vomiting
syndrome. Arch Dis Child. 2007;92:1001–4.
17. Ellingsen DM, Garcia RG, Lee J, Lin RL, Kim J, Thurler AH, Castel S, Dimisko L, Rosen BR,
Hadjikhani N, Kuo B, Napadow V.Cyclic vomiting syndrome is characterized by altered functional brain connectivity of the insular cortex: a cross-comparison with migraine and healthy
adults. Neurogastroenterol Motil. 2017;29(6):e13004. https://doi.org/10.1111/nmo.13004.
Epub 2016 Dec 1. PMID: 27910222; PMCID: PMC5423835.
18. Abu-Arafeh I, Gelfand AA. The childhood migraine syndrome. Nat Rev Neurol.
2021;17(7):449–58.
19. Raucci U, Borrelli O, Di Nardo G, Tambucci R, Pavone P, Salvatore S, Baldassarre ME,
Cordelli DM, Falsaperla R, Felici E, Ferilli MAN, Grosso S, Mallardo S, Martinelli D,
Quitadamo P, Pensabene L, Romano C, Savasta S, Spalice A, Strisciuglio C, Suppiej A,
Valeriani M, Zenzeri L, Verrotti A, Staiano A, Villa MP, Ruggieri M, Striano P, Parisi P.Cyclic
vomiting syndrome in children. Front Neurol. 2020;11:583425. https://doi.org/10.3389/
fneur.2020.583425. PMID: 33224097; PMCID: PMC7667239.
20. Beals L, Sarjinsky S, Faltyn M, Issenman RM, Kam AJ.Cyclic vomiting syndrome in the
emergency department: a 10-year review of clinical presentation and management. Pediatr
Emerg Care. 2022;38(10):e1578–83. https://doi.org/10.1097/PEC.0000000000002694. Epub
2022 May 12.
21. Abdulkader ZM, Bali N, Vaz K, Yacob D, Di Lorenzo C, Lu PL. Predictors of hospital
admission for pediatric cyclic vomiting syndrome. J Pediatr. 2021;232:154–8. https://doi.
org/10.1016/j.jpeds.2020.11.055. Epub 2020 Nov 28.
22. Wang-Hall J, Li BUK, Tarbell SE. Family health-related quality of life in pediatric cyclic
vomiting syndrome. J Pediatr Gastroenterol Nutr. 2018;66(5):738–43. https://doi.org/10.1097/
MPG.0000000000001797.
23. Lee LYW, Abbott L, Mahlangu B, Moodie SJ, Anderson S.The management of cyclic vomiting syndrome: a systematic review. Eur J Gastroenterol Hepatol. 2012;24:1001–6.
24. Isoldi S, Di Nardo G, Mallardo S, etal. Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology,
Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP). Ital
J Pediatr. 2022;48(1):156.
PMCID: PMC9429644.
https://doi.org/10.1186/s13052- 022- 01346- y. PMID: 36042474;
I. Abu-Arafeh

6 Episodic Syndromes That May Be Associated with Migraine: Cyclical Vomiting…
25. Li BUK.Treating cyclic vomiting syndrome in the emergency department: sooner appears
better. J Pediatr. 2021;232:12–4. https://doi.org/10.1016/j.jpeds.2020.12.066. Epub
2020 Dec 26.
26. Hikita T, Kodama H, Kaneko S, Amakata K, Ogita K, Mochizuki D, Kaga F, Nakamoto
N, Fujii Y, Kikuchi A.Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical
trial. Cephalalgia. 2011;31(4):504–7. https://doi.org/10.1177/0333102410390398. Epub
2010 Dec 8.
27. Tillman EM, Harvath EM.Cyclic Vomiting Syndrome in Pediatric Patients: A Review of
Therapeutics. J Pediatr Pharmacol Ther. 2022;27(1):12–8.
27.1.12. Epub 2021 Dec 22. PMID: 35002554; PMCID: PMC8717616.
28. Tarbell SE.LI BUK, health -related quality of life in children and adolescents with cyclic
vomiting syndrome: a comparison with published data on youth with irritable bowel syndrome
and organic gastrointestinal disorders. J Pediatr. 2013;163:493–7.
29. Dignan F, Symon DNK, Abu-Arafeh I, Russell G.The prognosis of cyclical vomiting syndrome. Arch Dis Child. 2001;84:55–7.
https://doi.org/10.5863/1551- 6776-
59

Chapter 7
Episodic Syndromes That May
BeAssociated withMigraine: Abdominal
Migraine
ArifeCimenAtalar, EbruNurVanli-Yavuz, andPinarTopaloğlu
7.1 Introduction
Abdominal migraine (AM) is a member of a group of syndromes known as “the
episodic syndromes associated with migraine” including recurrent gastrointestinal
(GI) disturbance (1.6.1) (cyclic vomiting syndrome [1.6.1.1] and AM [1.6.1.2]),
benign paroxysmal vertigo (1.6.2), and benign paroxysmal torticollis (1.6.3) [1].
AM is considered the most common childhood periodic syndrome seen in a pediatric headache clinic, accounting for 48.9% of cases in one study [2]. Studies suggest a higher prevalence in girls, though some indicate equal distribution between
genders [3].
Although it is recognized as a disorder of childhood, it can also be encountered
in adults where it is frequently underrecognized and can be quite challenging for
clinicians dealing with these patients [4]. According to the latest version of the
International Classication of Headache Disorders (ICHD-3), it is dened as an
idiopathic condition of recurrent attacks of midline abdominal pain with moderateto- severe intensity concomitant with vasomotor symptoms such as anorexia, pallor,
nausea, and vomiting [1]. The presence of renal or gastrointestinal disease should be
ruled out for accurate diagnosis; hence a detailed differential diagnosis should be
A. C. Atalar
Department of Neurology, Istanbul Physical Therapy and Rehabilitation Training and
Research Hospital, Istanbul, Turkey
E. N. Vanli-Yavuz
Mediclinic City Hospital Dubai, Dubai, UAE
P. Topaloğlu (
Division of Child Neurology, Department of Neurology, Istanbul Faculty of Medicine,
Istanbul University, Istanbul, Turkey
Switzerland AG 2026
D. Uludüz et al. (eds.), Rare Causes of Headache Disorders, Headache,
https://doi.org/10.1007/978-3-032-10242-3_7
*)
61© The Author(s), under exclusive license to Springer Nature
Соседние файлы в папке Библиотека им академика М.И. Перельмана
